These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37594691)

  • 1. Quo Vadis Forensic Neuropsychological Malingering Determinations? Reply to Drs. Bush, Faust, and Jewsbury.
    Leonhard C
    Neuropsychol Rev; 2023 Sep; 33(3):653-657. PubMed ID: 37594691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of Statistical and Methodological Issues in the Forensic Prediction of Malingering from Validity Tests: Part II-Methodological Issues.
    Leonhard C
    Neuropsychol Rev; 2023 Sep; 33(3):604-623. PubMed ID: 37594690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-positive rates associated with the use of multiple performance and symptom validity tests.
    Larrabee GJ
    Arch Clin Neuropsychol; 2014 Jun; 29(4):364-73. PubMed ID: 24769887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidimensional Malingering Criteria for Neuropsychological Assessment: A 20-Year Update of the Malingered Neuropsychological Dysfunction Criteria.
    Sherman EMS; Slick DJ; Iverson GL
    Arch Clin Neuropsychol; 2020 Aug; 35(6):735-764. PubMed ID: 32377667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of Statistical and Methodological Issues in the Forensic Prediction of Malingering from Validity Tests: Part I: Statistical Issues.
    Leonhard C
    Neuropsychol Rev; 2023 Sep; 33(3):581-603. PubMed ID: 37612531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggregation across multiple indicators improves the detection of malingering: relationship to likelihood ratios.
    Larrabee GJ
    Clin Neuropsychol; 2008 Jul; 22(4):666-79. PubMed ID: 17886147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical Evaluation Board Involvement, Non-Credible Cognitive Testing, and Emotional Response Bias in Concussed Service Members.
    Mooney SR; Stafford J; Seats E
    Mil Med; 2018 Nov; 183(11-12):e546-e554. PubMed ID: 29590406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of MMPI-2-RF Symptom Validity Scales and Performance Validity Test Relationships in a Diverse Mixed Neuropsychiatric Setting.
    De Boer AB; Phillips MS; Barwegen KC; Obolsky MA; Rauch AA; Pesanti SD; Tse PKY; Ovsiew GP; Jennette KJ; Resch ZJ; Soble JR
    Psychol Inj Law; 2023; 16(1):61-72. PubMed ID: 36348958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing between neuropsychological malingering and exaggerated psychiatric symptoms in a neuropsychological setting.
    Ruocco AC; Swirsky-Sacchetti T; Chute DL; Mandel S; Platek SM; Zillmer EA
    Clin Neuropsychol; 2008 May; 22(3):547-64. PubMed ID: 17853126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptom and performance validity in neuropsychological assessments of outpatients 15-30 years of age.
    Boe EW; Evald L
    Brain Inj; 2022 Dec; ():1-7. PubMed ID: 36527248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-Daubert admissibility of scientific evidence on malingering of cognitive deficits.
    Vallabhajosula B; van Gorp WG
    J Am Acad Psychiatry Law; 2001; 29(2):207-15. PubMed ID: 11471788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance and symptom validity assessment in attention deficit/hyperactivity disorder: Base rates of invalidity, concordance, and relative impact on cognitive performance.
    Ovsiew GP; Cerny BM; Boer AB; Petry LG; Resch ZJ; Durkin NM; Soble JR
    Clin Neuropsychol; 2023 Oct; 37(7):1498-1515. PubMed ID: 36594201
    [No Abstract]   [Full Text] [Related]  

  • 13. Types or modes of malingering? A confirmatory factor analysis of performance and symptom validity tests.
    Egeland J; Andersson S; Sundseth ØØ; Schanke AK
    Appl Neuropsychol Adult; 2015; 22(3):215-26. PubMed ID: 25275555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance validity and symptom validity in neuropsychological assessment.
    Larrabee GJ
    J Int Neuropsychol Soc; 2012 Jul; 18(4):625-30. PubMed ID: 23057079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TOMM Trial 1 as a performance validity indicator in a criminal forensic sample.
    Fazio RL; Denning JH; Denney RL
    Clin Neuropsychol; 2017 Jan; 31(1):251-267. PubMed ID: 27456971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance validity and symptom validity tests: Are they measuring different constructs?
    Ord AS; Shura RD; Sansone AR; Martindale SL; Taber KH; Rowland JA
    Neuropsychology; 2021 Mar; 35(3):241-251. PubMed ID: 33829824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical guidelines in the use of symptom validity and other psychological tests to measure malingering and symptom exaggeration in traumatic brain injury cases.
    Etcoff LM; Kampfer KM
    Neuropsychol Rev; 1996 Dec; 6(4):171-201. PubMed ID: 9159771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Performance Validity Measures in Predicting MMPI-2 Lie Scale Results.
    Richey LN; Doninger NA
    Clin Neuropsychol; 2020 Feb; 34(2):353-367. PubMed ID: 31340718
    [No Abstract]   [Full Text] [Related]  

  • 19. The MMPI-2/MMPI-2-RF Symptom Validity Scale (FBS/FBS-r) is not a measure of 'litigation response syndrome': commentary on Nichols and Gass (2015).
    Larrabee GJ; Bianchini KJ; Boone KB; Rohling ML
    Clin Neuropsychol; 2017 Nov; 31(8):1387-1395. PubMed ID: 28829224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric implications of failure on one performance validity test: a cross-validation study to inform criterion group definition.
    Rhoads T; Neale AC; Resch ZJ; Cohen CD; Keezer RD; Cerny BM; Jennette KJ; Ovsiew GP; Soble JR
    J Clin Exp Neuropsychol; 2021 Jul; 43(5):437-448. PubMed ID: 34233580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.